Silk Road Medical, Inc
Symbool: SILK
NASDAQ
18.97
USDMarktprijs vandaag
-15.0008
Koers/Winst Verhouding
0.1739
Koers/Winst Groei Verhouding
743.14M
MRK Kapitalisatie
- 0.00%
DIV Rendement
Silk Road Medical, Inc (SILK) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 181.5 | 213.7 | 110.2 | |||||||
balance-sheet.row.short-term-investments | 0 | 161.3 | 158.3 | 0 | |||||||
balance-sheet.row.net-receivables | 0 | 23.6 | 18 | 11.8 | |||||||
balance-sheet.row.inventory | 0 | 29.9 | 19.3 | 17.9 | |||||||
balance-sheet.row.other-current-assets | 0 | 5.9 | 3.9 | 3.4 | |||||||
balance-sheet.row.total-current-assets | 0 | 240.8 | 254.9 | 143.3 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 14.6 | 9.4 | 7.7 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0.1 | 0.1 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0.1 | 0.1 | |||||||
balance-sheet.row.long-term-investments | 0 | 9.5 | 0.2 | 0.2 | |||||||
balance-sheet.row.tax-assets | 0 | 0 | -0.2 | -0.3 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 0.4 | 5.3 | 5.6 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 24.5 | 14.8 | 13.3 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 265.3 | 269.7 | 156.6 | |||||||
balance-sheet.row.account-payables | 0 | 5.7 | 2.5 | 2.4 | |||||||
balance-sheet.row.short-term-debt | 0 | 1.7 | 1.8 | 3.9 | |||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 75.6 | 74.6 | 44.8 | |||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 22.8 | 19.9 | 19.6 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 83.9 | 81.3 | 51.3 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 7.3 | 1.8 | 1.3 | |||||||
balance-sheet.row.total-liab | 0 | 114.2 | 105.8 | 77.4 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.retained-earnings | 0 | -399.5 | -343.7 | -288.7 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0.1 | -0.2 | 0 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 550.5 | 507.7 | 367.9 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 151.2 | 163.9 | 79.2 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 265.3 | 269.7 | 156.6 | |||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-equity | 0 | 151.2 | 163.9 | 79.2 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 170.7 | 158.3 | 0.2 | |||||||
balance-sheet.row.total-debt | 0 | 84.6 | 76.4 | 48.7 | |||||||
balance-sheet.row.net-debt | 0 | 64.4 | 21.1 | -61.5 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -55.7 | -55 | -49.8 | |||||||
cash-flows.row.depreciation-and-amortization | 0 | 3.8 | 3.2 | 1.9 | |||||||
cash-flows.row.deferred-income-tax | 0 | -59.8 | 0 | 0.7 | |||||||
cash-flows.row.stock-based-compensation | 0 | 38.9 | 25 | 14.6 | |||||||
cash-flows.row.change-in-working-capital | 0 | -13.9 | -6 | -6.5 | |||||||
cash-flows.row.account-receivables | 0 | -5.6 | -6.2 | -2.8 | |||||||
cash-flows.row.inventory | 0 | -10.8 | -1.4 | -5.6 | |||||||
cash-flows.row.account-payables | 0 | 3.1 | 1 | -1.2 | |||||||
cash-flows.row.other-working-capital | 0 | -0.6 | 0.6 | 3 | |||||||
cash-flows.row.other-non-cash-items | 0 | 54.8 | 0.3 | 0.2 | |||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1.5 | -5 | -4.8 | |||||||
cash-flows.row.acquisitions-net | 0 | 0 | 157.1 | 0 | |||||||
cash-flows.row.purchases-of-investments | 0 | -175 | -168.2 | 0 | |||||||
cash-flows.row.sales-maturities-of-investments | 0 | 169.3 | 11.1 | 77.4 | |||||||
cash-flows.row.other-investing-activites | 0 | 0 | -157.1 | 0 | |||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -7.2 | -162.1 | 72.6 | |||||||
cash-flows.row.debt-repayment | 0 | 0 | -49 | 0 | |||||||
cash-flows.row.common-stock-issued | 0 | 3.9 | 114.8 | 6.9 | |||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-financing-activites | 0 | 0 | 73.9 | 0 | |||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3.9 | 139.7 | 7 | |||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.2 | 0 | 0 | |||||||
cash-flows.row.net-change-in-cash | 0 | -35.1 | -55 | 40.7 | |||||||
cash-flows.row.cash-at-end-of-period | 0 | 20.2 | 55.5 | 110.5 | |||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 55.4 | 110.5 | 69.8 | |||||||
cash-flows.row.operating-cash-flow | 0 | -32 | -32.6 | -38.9 | |||||||
cash-flows.row.capital-expenditure | 0 | -1.5 | -5 | -4.8 | |||||||
cash-flows.row.free-cash-flow | 0 | -33.5 | -37.6 | -43.7 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 177.1 | 138.6 | 101.5 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 50 | 37.9 | 25.4 | |||||||
income-statement-row.row.gross-profit | 0 | 127.1 | 100.8 | 76 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | 0.4 | -0.2 | 0 | |||||||
income-statement-row.row.operating-expenses | 0 | 186.4 | 152.8 | 123.5 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 236.4 | 190.6 | 148.9 | |||||||
income-statement-row.row.interest-income | 0 | 10 | 2.5 | 0.2 | |||||||
income-statement-row.row.interest-expense | 0 | 6.9 | 5.1 | 2.5 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | 3.5 | -3 | -2.3 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | 0.4 | -0.2 | 0 | |||||||
income-statement-row.row.total-operating-expenses | 0 | 3.5 | -3 | -2.3 | |||||||
income-statement-row.row.interest-expense | 0 | 6.9 | 5.1 | 2.5 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 3.8 | 2.3 | 0.2 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | -59.3 | -52 | -47.5 | |||||||
income-statement-row.row.income-before-tax | 0 | -55.7 | -55 | -49.8 | |||||||
income-statement-row.row.income-tax-expense | 0 | 0 | 3 | 0.6 | |||||||
income-statement-row.row.net-income | 0 | -55.7 | -58 | -50.4 |
Vaak gestelde vragen
Wat is Silk Road Medical, Inc (SILK) totale activa?
Silk Road Medical, Inc (SILK) totale activa is 265309000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.733.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.288.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.309.
Wat is Silk Road Medical, Inc (SILK) nettowinst (netto-inkomen)?
De nettowinst is -55743000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 84633000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 186357000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.